- Home
- VIVK vs BOLD Comparison
VIVK vs BOLD Comparison
Compare VIVK & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- BOLD
- Stock Information
- Founded
- VIVK 2006
- BOLD 2018
- Country
- VIVK United States
- BOLD United States
- Employees
- VIVK N/A
- BOLD N/A
- Industry
- VIVK Oilfield Services/Equipment
- BOLD
- Sector
- VIVK Energy
- BOLD
- Exchange
- VIVK Nasdaq
- BOLD Nasdaq
- Market Cap
- VIVK 34.5M
- BOLD 30.3M
- IPO Year
- VIVK N/A
- BOLD 2024
- Fundamental
- Price
- VIVK $0.87
- BOLD $1.07
- Analyst Decision
- VIVK
- BOLD Buy
- Analyst Count
- VIVK 0
- BOLD 3
- Target Price
- VIVK N/A
- BOLD $4.00
- AVG Volume (30 Days)
- VIVK 2.0M
- BOLD 260.9K
- Earning Date
- VIVK 08-15-2025
- BOLD 08-11-2025
- Dividend Yield
- VIVK N/A
- BOLD N/A
- EPS Growth
- VIVK N/A
- BOLD N/A
- EPS
- VIVK N/A
- BOLD N/A
- Revenue
- VIVK $111,130,140.00
- BOLD N/A
- Revenue This Year
- VIVK N/A
- BOLD N/A
- Revenue Next Year
- VIVK N/A
- BOLD N/A
- P/E Ratio
- VIVK N/A
- BOLD N/A
- Revenue Growth
- VIVK 85.84
- BOLD N/A
- 52 Week Low
- VIVK $0.55
- BOLD $1.00
- 52 Week High
- VIVK $3.45
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- VIVK 51.74
- BOLD N/A
- Support Level
- VIVK $0.81
- BOLD N/A
- Resistance Level
- VIVK $1.01
- BOLD N/A
- Average True Range (ATR)
- VIVK 0.12
- BOLD 0.00
- MACD
- VIVK 0.01
- BOLD 0.00
- Stochastic Oscillator
- VIVK 58.99
- BOLD 0.00
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.